Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.

Cabanillas, Maria E

Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. [electronic resource] - The Journal of clinical endocrinology and metabolism Jun 2010 - 2588-95 p. digital

Publication Type: Journal Article

1945-7197

10.1210/jc.2009-1923 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Benzenesulfonates--administration & dosage
DNA Mutational Analysis
Disease Progression
Disease-Free Survival
Female
Humans
Indoles--administration & dosage
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Metastasis
Niacinamide--analogs & derivatives
Off-Label Use
Phenylurea Compounds
Protein Kinase Inhibitors--administration & dosage
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyridines--administration & dosage
Pyrroles--administration & dosage
Sorafenib
Sunitinib
Survival Analysis
Thyroglobulin--blood
Thyroid Neoplasms--diagnostic imaging
Tomography, X-Ray Computed
Treatment Outcome